Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Intern Med ; 55(10): 1327-9, 2016.
Article in English | MEDLINE | ID: mdl-27181541

ABSTRACT

A 79-year-old man on hemodialysis was hospitalized for further investigation. Early gastric cancer was diagnosed by gastrointestinal endoscopy and endoscopic submucosal dissection (ESD) was performed. Fever and abdominal pain thereafter developed, and a severe inflammatory response was observed on a blood test. Contrast computed tomography (CT) showed ulcer-like projections and soft tissue surrounding the aorta, from the celiac to left renal artery. An infected aneurysm was diagnosed. Although infected aneurysms developing after laparoscopic cholecystectomy or biopsy of contiguous esophageal duplication cyst have been reported, those developing after ESD have not. When fever and abdominal pain develop after ESD, an infected aneurysm should be considered and contrast CT performed.


Subject(s)
Aneurysm, Infected/etiology , Endoscopic Mucosal Resection/adverse effects , Aged , Gastric Mucosa/pathology , Humans , Male , Stomach Neoplasms/diagnosis , Stomach Neoplasms/pathology , Tomography, X-Ray Computed
2.
Int J Oncol ; 36(4): 765-75, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20198318

ABSTRACT

Abundant mucin production and MUC2 expression is the key feature of mucinous colorectal cancer (CRC). Although MUC2 gene methylation has been thought to play an important role in loss of MUC2 expression, the tissues are difficult to analyze because of the cellular heterogeneity of tissue samples. In the present study, we determined the role of region-specific methylation in the MUC2 promoter in MUC2 expression in CRC. Additionally, we optimized the conditions for quantification of methylation analysis in mucinous and non-mucinous CRC tissues. We identified two regions in MUC2 promoter, region A (-289 and -274) and region C (-193 and -160), that correlated with loss of MUC2 expression by comparing the methylation status in 13 CRC cell lines with no or low MUC2 expression and those in 4 cell lines with high MUC2 expression. To prove the correlation of MUC2 methylation status and loss of expression in CRC tissues, MUC2 methylation status in tumors needs to be determined. Since the critical CpG sites have been identified in cell lines by sequencing, a more rapid and sensitive methylation specific PCR (MSP) was used. We conducted MSP at 3 CpG sites (-289, -274, -193) in 19 mucinous and 34 non-mucinous CRC tissues because this analysis worked at only these sites in the preliminary cell line experiments. Our results showed that methylation status of mucinous CRC was significantly lower than that of non-mucinous CRC at 3 sites (-289; p=0.001, -274; p=0.013, -193; p=0.001), and correlated with high level of MUC2 expression as determined by immunohistochemistry. Besides, these results indicated that MUC2 expression and mucin contents decreased in accordance with the increase of methylation status. We concluded that low methylation status of MUC2 gene plays a predominant role in high level MUC2 expression in mucinous CRC.


Subject(s)
Adenocarcinoma, Mucinous/genetics , Colorectal Neoplasms/genetics , DNA Methylation , Mucin-2/genetics , Promoter Regions, Genetic , Adenocarcinoma, Mucinous/chemistry , Adenocarcinoma, Mucinous/pathology , Aged , Aged, 80 and over , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/pathology , CpG Islands , Female , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Male , Middle Aged , Mucin-2/analysis , Neoplasm Staging , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction
3.
Int J Oncol ; 35(4): 741-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19724910

ABSTRACT

The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity. Pancreas cancer patients with B7-H1 expression have a poor prognosis. B7-H1 blocking has been shown to inhibit the development of a subcutaneous tumor from a pancreas cancer cell line. In this study, we investigated the effects of B7-DC as well as B7-H1 blockade in vivo in a murine pancreatic cancer model. Pancreatic cancer cells (Panc02) were inoculated in the pancreas of C57BL/6 mice. Five weeks later, tumor sizes were measured and the mice bearing appropriate size of tumors received the following treatments. Blocking antibodies against B7-H1 or B7-DC (200 microg) were administered 3 times/week for 3 weeks. Cells infiltrating the tumors were characterized by immunohistochemistry. Effects of antibodies on cytokine and FoxP3 expression were examined by quantitative RT-PCR. In vitro cultured Panc02 cells expressed B7-H1 upon IFN-gamma stimulation. However, expression of B7-H1 and B7-DC was found mainly on CD45-positive infiltrating cells and rarely on cancer cells in vivo. Treatment with both antibodies significantly decreased tumor growth in vivo. B7-DC blockade decreased the levels of IL-10 and FoxP3, suggesting that regulatory systems are mainly inhibited at the tumor site. B7-H1 blockade increased the levels of IFN-gamma and FoxP3. Collectively, blocking of B7-H1 or B7-DC efficiently induced regression of pre-established pancreatic cancers by up-regulating IFN-gamma production and down-regulating IL-10 production at the tumor site.


Subject(s)
Adenocarcinoma/drug therapy , Antibodies, Blocking/pharmacology , Antigens, Differentiation/immunology , Antineoplastic Agents/pharmacology , B7-1 Antigen/drug effects , Membrane Glycoproteins/antagonists & inhibitors , Pancreatic Neoplasms/drug therapy , Peptides/antagonists & inhibitors , Tumor Escape/drug effects , Adenocarcinoma/genetics , Adenocarcinoma/immunology , Adenocarcinoma/pathology , Animals , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , B7-1 Antigen/immunology , B7-H1 Antigen , CD11b Antigen/analysis , CD4 Antigens/analysis , CD8 Antigens/analysis , Cell Line, Tumor , Cell Proliferation/drug effects , Forkhead Transcription Factors/genetics , Interferon-gamma/genetics , Interferon-gamma/metabolism , Interleukin-10/genetics , Leukocyte Common Antigens/analysis , Lymphocytes, Tumor-Infiltrating/drug effects , Lymphocytes, Tumor-Infiltrating/immunology , Male , Membrane Glycoproteins/immunology , Mice , Mice, Inbred C57BL , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/immunology , Pancreatic Neoplasms/pathology , Peptides/immunology , Programmed Cell Death 1 Ligand 2 Protein , Programmed Cell Death 1 Receptor , RNA, Messenger/metabolism , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology
4.
Microcirculation ; 16(3): 251-64, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19225984

ABSTRACT

OBJECTIVE: Although enterobacteria are implicated in intestinal immune response, there has been no report on how intraluminal pathogens affect lymphocyte recruitment. The aim of this study was to determine how the presence of intestinal flora affects lymphocyte migration to intestine under physiological and lipopolysaccharide (LPS)-induced inflammatory conditions. METHODS: Interaction of T-cells with ileal microvessels was monitored by using an intravital microscope in mice under germ-free (GF) and specific pathogen-free (SPF) conditions. LPS was administered into either the peritoneal cavity or duodenum before lymphocyte injection. RESULTS: Adherence of T-cells was greater in SPF than in GF mice, indicating that the presence of enterobacteria upregulated migration under physiological conditions. Intraperitoneally administered LPS significantly increased the adherence of T-cells in both GF and SPF mice accompanied by the expression of adhesion molecules and proinflammatory cytokines. However, intraluminally administered LPS did not enhance the adherence of T-cells in SPF mice. A significant induction of increase in mRNA expression of IRAK-M, a negative regulator of TLR4 signaling, and transforming growth factor beta (TGF-beta), a regulatory cytokine, was observed in SPF mice after luminal LPS treatment. CONCLUSIONS: Tolerance to intraluminally administered LPS in the lymphocyte recruitment process was induced by enterobacteria, possibly via the induction of IRAK-M and TGF-beta.


Subject(s)
Chemotaxis, Leukocyte , Enterobacteriaceae/immunology , Immune Tolerance/immunology , Interleukin-1 Receptor-Associated Kinases/immunology , Intestines/blood supply , Lymphocytes/immunology , Microvessels/immunology , Signal Transduction/immunology , Toll-Like Receptor 4/immunology , Transforming Growth Factor beta/immunology , Animals , Cell Adhesion Molecules , Endothelium , Lipopolysaccharides/pharmacology , Mice , Toll-Like Receptors , Transcriptional Activation/immunology , Transforming Growth Factor beta/genetics
5.
Inflamm Bowel Dis ; 14(10): 1348-57, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18484673

ABSTRACT

BACKGROUND: Although the immunoregulatory effects of omega-3 fatty acid and adiponectin have been postulated, their role in intestinal inflammation is controversial. The aim of this study was to determine whether dietary fat intake influences activity of colonic inflammation through modulating this system. METHODS: C57BL/6 mice received dextran sulfate sodium for induction of colitis. Mice were fed a control diet, omega-3 fat-rich diet, omega-6 fat-rich diet, or saturated fat-rich diet. Some mice were administered a peroxisome proliferator activated receptor-gamma; agonist, pioglitazone. Messenger RNA expression of adiponectin and its receptors were analyzed. Adiponectin expression in colonic mucosa of ulcerative colitis patients was also analyzed. RESULTS: The receptors for adiponectin were found to be ubiquitously expressed in epithelial cells, intraepithelial lymphocytes, lamina proprial mononuclear cells, and subepithelial myofibroblasts from colonic tissue, but adiponectin was only expressed in myofibroblasts. Induction of colitis significantly decreased the expression of adiponectin in colonic mucosa. The omega-3 fat diet group, but not the other fat diet groups, showed exacerbated colitis with a further decrease of adiponectin expression. Pioglitazone treatment ameliorated the level of decrease in adiponectin expression and improved colonic inflammation induced by the omega-3 fat-rich diet. In patients with ulcerative colitis, the expression level of adiponectin in colonic mucosa was also decreased compared with that in control mucosa. CONCLUSIONS: Adiponectin was found to be expressed in myofibroblasts. Adiponectin expression was significantly suppressed by induction of colitis, and aggravation of colitis after exposure to omega-3 fat may be due to a further decrease in the expression level of adiponectin.


Subject(s)
Adiponectin/metabolism , Colitis/chemically induced , Colitis/drug therapy , Dietary Fats, Unsaturated/administration & dosage , Fatty Acids, Omega-3/administration & dosage , Myoblasts/metabolism , Adiponectin/genetics , Animals , Anti-Inflammatory Agents/administration & dosage , Cells, Cultured , Colitis/metabolism , Colitis/pathology , Dextran Sulfate/toxicity , Dietary Fats/administration & dosage , Disease Models, Animal , Fatty Acids, Omega-6/administration & dosage , Gene Expression , Humans , Intestinal Mucosa/metabolism , Male , Mice , Mice, Inbred C57BL , Pioglitazone , RNA, Messenger/metabolism , Random Allocation , Reverse Transcriptase Polymerase Chain Reaction , Thiazolidinediones
6.
Microcirculation ; 14(3): 241-51, 2007.
Article in English | MEDLINE | ID: mdl-17454676

ABSTRACT

OBJECTIVE: Although monocyte infiltration is an important aspect of the host response to tumor growth, the mechanisms of recruitment and their impact on tumor growth are still unknown. The authors studied monocyte-endothelial interaction and the effect of chemokine CCL2 in orthotopic mouse pancreatic cancer. METHODS: The rolling and adhesion of labeled monocytes in peritumoral and intratumoral areas were assessed by using an intravital microscope. Further, the effects of intratumoral injection or superfusion of CCL2 on in situ recruitment of monocytes and other immune cells and adhesion molecules were investigated. RESULTS: More monocytes were recruited in the peritumoral area than in the intratumoral area with increased vascular interaction, and the effect was more apparent by intratumoral CCL2 injection than superfusion. In both CCL2-treated groups infiltration of CD11b(+), CD68(+), and CD4(+) cells were increased, but the magnitude of increase was larger in intratumoral injection. Quantitative RT-PCR for the tumor tissue revealed that ICAM-1 expression was increased by the injection of CCL2. CONCLUSION: These results show intratumoral injection of CCL2 induces effective interaction between monocytes and endothelial cells in the peritumoral area of pancreatic cancer accompanied by the upregulation of ICAM-1 and may possibly become a tool for immunotherapy by promoting the infiltration of immune cells in cancers.


Subject(s)
Cell Communication/immunology , Chemokine CCL2/immunology , Endothelium, Vascular/immunology , Intercellular Adhesion Molecule-1/immunology , Leukocyte Rolling/immunology , Monocytes/immunology , Pancreatic Neoplasms/immunology , Animals , Antigens, CD/immunology , Cell Communication/drug effects , Chemokine CCL2/administration & dosage , Endothelium, Vascular/pathology , Immunity, Cellular , Immunotherapy , Injections, Intralesional , Intercellular Adhesion Molecule-1/biosynthesis , Leukocyte Rolling/drug effects , Male , Mice , Mice, Inbred C57BL , Monocytes/pathology , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/therapy , Recombinant Proteins/administration & dosage , Recombinant Proteins/immunology , Up-Regulation/drug effects , Up-Regulation/immunology
7.
Nihon Shokakibyo Gakkai Zasshi ; 103(12): 1366-71, 2006 Dec.
Article in Japanese | MEDLINE | ID: mdl-17148925

ABSTRACT

A 68-years-old Japanese woman was hospitalized emergently because of hemorrhagic gastric ulcer. For the hospitalization period, elevated levels of white blood cell count, eosinophilic leucocyte count, serum IgE and positive MPO-ANCA were recognized. With considering clinical course and these laboratory findings, we diagnosed Churg-Strauss syndrome (CSS). Steroid therapy in combination with cyclophosphamide was effective. CSS is a rare disease, but we should discriminate this disease when we encounter gastrointestinal bleeding of unknown etiology, especially PPI-resistant gastric ulcer.


Subject(s)
Churg-Strauss Syndrome/diagnosis , Hematemesis/etiology , Peptic Ulcer Hemorrhage/complications , Stomach Ulcer/complications , Aged , Churg-Strauss Syndrome/drug therapy , Cyclophosphamide/administration & dosage , Drug Therapy, Combination , Female , Humans , Methylprednisolone/administration & dosage , Pulse Therapy, Drug
12.
J Gastroenterol ; 39(2): 176-80, 2004.
Article in English | MEDLINE | ID: mdl-15069626

ABSTRACT

An autopsy case of adenosquamous pancreatic cancer in a 61-year-old male patient with an elevated serum level of parathyroid hormone-related protein (PTH-rP) is reported. He was admitted to our hospital with a 1-month-long history of abdominal discomfort and progressive abdominal fullness. A computed tomography (CT) scan of the abdomen showed a retroperitoneal mass, approximately 10 cm in diameter, involving the pancreas, with round enhancement on contrast examination. Histological examination of a specimen taken by CT-guided needle biopsy suggested squamous cell carcinoma or transitional cell carcinoma. Laboratory data on admission revealed a high serum calcium level and high PTH-rP level. The calcium level initially responded to intravenous hydration, furosemide, calcitonin, and bisphosphonates, decreasing from 15.0 to 9.0 mg/dl. However, the hypercalcemia recurred after 10 days. The patient developed carcinomatous peritonitis and acute renal failure, and died on the 25th hospital day. Autopsy revealed a mass in the pancreatic body to tail, invading the retroperitoneum, with progressive carcinomatous peritonitis. Histological examination of the mass revealed infiltrating carcinoma, showing squamous differentiation with focal intracytoplasmic lumina formation, consistent with pancreatic adenosquamous carcinoma. Immunohistological examination showed positive staining for PTH-rP. Adenosquamous carcinoma of the pancreas is relatively rare; only a few cases associated with hypercalcemia and for which PTH-rP has been identified as a causative factor have been reported. This is the first case in which immunohistochemistry proved localized PTH-rP in adenosquamous pancreatic cancer cells, associated with persistent hypercalcemia.


Subject(s)
Calcium/blood , Carcinoma, Adenosquamous/blood , Hypercalcemia/blood , Pancreatic Neoplasms/blood , Parathyroid Hormone-Related Protein/blood , Carcinoma, Adenosquamous/diagnosis , Carcinoma, Adenosquamous/pathology , Humans , Hypercalcemia/complications , Magnetic Resonance Imaging , Male , Middle Aged , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/pathology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...